Clinical trial reveals twice-yearly injection reduces risk of HIV infection by 96% - Medical Xpress
- Clinical trial reveals twice-yearly injection reduces risk of HIV infection by 96% Medical Xpress
- Gilead Sciences: Designing Inclusive Clinical Trials in an Effort To Upend the HIV Epidemic CSRwire.com
- Gilead's Scientific Innovation at the Forefront of Helping End the HIV Epidemic Gilead Sciences
- 'Huge relief' as new drug found to effectively prevent HIV infection Yahoo! Voices
- Lead Gilead researcher highlights need for inclusive clinical trials for HIV Clinical Trials Arena